Human Life CORD Japan Inc. jobs and careers

About Human Life CORD Japan Inc.

HLC builds an economic ecosystem for umbilical cord-based cell therapy and contribute to protecting people's lives and health. -Serum-free manufactured off-the-shelf umbilical cord-derived mesenchymal stromal cells (HLC-MSCs) have significant advantages over other sourced MSCs in terms of proliferation, homogeneity, and cost efficiency. -The technologies for manufacturing, storing, and evaluating HLC- MSCs, which originated at the Institute of Medical Science, University of Tokyo, are highly advanced, and HLC will standardize these technologies to make them available around the world. -The versatility of MSC has only been partially utilized. Based on evidence, HLC will utilize HLC-MSCs in a wide range of applications, from treating serious diseases to promoting healthy lifespan.